Kamada (KMDA) Cash from Investing Activities (2013 - 2026)

Kamada (KMDA) reported Cash from Investing Activities of -$41.2 million for Q1 2026, down 2721.78% on a YoY basis from $1.6 million in Q1 2025, and down 1384.61% quarter-over-quarter from -$2.8 million in Q4 2025.

Kamada (KMDA) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Kamada has reported Cash from Investing Activities for 14 years, with the latest figure at -$41.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 2721.78% year-over-year to -$41.2 million; the trailing twelve-month figure through Mar 2026 stood at -$49.6 million (down 420.92% YoY), and the FY2025 full-year result was -$9.8 million, up 8.39% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$41.2 million, down from -$2.8 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$1093.0 in Q1 2023, with the low at -$41.2 million in Q1 2026.
  • Historically, Cash from Investing Activities has averaged -$4.0 million across 5 years, with a median of -$2.0 million in 2023.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 99.79% — and 2024, when it slumped 245279.69%.
  • Kamada's Cash from Investing Activities stood at -$977000.0 in 2022, then plunged by 101.94% to -$2.0 million in 2023, then slumped by 48.2% to -$2.9 million in 2024, then grew by 5.1% to -$2.8 million in 2025, then tumbled by 1384.61% to -$41.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$41.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Kamada 504.70 -73.15 Mn 19.12 Mn -41.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -41.20 Mn
Mar 31, 2026 -41.20 Mn
Dec 31, 2025 -2.78 Mn
Dec 31, 2025 -2.78 Mn
Sep 30, 2025 -3.59 Mn
Sep 30, 2025 -3.59 Mn
Jun 30, 2025 -2.01 Mn
Jun 30, 2025 -2.01 Mn
Mar 31, 2025 -1.46 Mn
Mar 31, 2025 -1.46 Mn
Dec 31, 2024 -2.92 Mn
Dec 31, 2024 -2.92 Mn
Sep 30, 2024 -2.12 Mn
Sep 30, 2024 -2.12 Mn
Jun 30, 2024 -3.01 Mn
Jun 30, 2024 -3.01 Mn
Mar 31, 2024 -2.68 Mn
Mar 31, 2024 -2.68 Mn
Dec 31, 2023 -1.97 Mn
Dec 31, 2023 -1.97 Mn